Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 296 entries
View as:

18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00654745 Org: User:
Start: 05/31/08 End: 06/30/09 Due: 06/30/10

Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00107900 Org: User:
Start: 01/31/05 End: 12/31/05 Due: 12/31/06

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

Phase: N/A Priority: Normal
NCT ID: NCT04656652 Org: User:
Start: 12/21/20 End: 01/31/26 Due: 01/31/27

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01565668 Org: User:
Start: 04/30/12 End: 03/31/15 Due: 03/31/16

Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03901313 Org: User:
Start: 04/01/19 End: 05/22/19 Due: 05/22/20

Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations

Phase: N/A Priority: Normal
NCT ID: NCT05215340 Org: User:
Start: 03/04/22 End: 04/30/28 Due: 04/30/29

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06731478 Org: User:
Start: 02/27/25 End: 02/01/30 Due: 02/01/31

Effect of Combination Therapy With Two Drugs (Colesevelam and Ezetimibe) in Patients With High Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00185107 Org: User:
Start: 03/31/05 End: 10/31/05 Due: 10/31/06

Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00902538 Org: User:
Start: 04/30/09 End: 10/31/10 Due: 10/31/11

Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00061854 Org: User:
Start: 04/30/03 End: 05/31/05 Due: 05/31/06

A Study of DS-9606a in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05394675 Org: User:
Start: 05/31/22 End: 02/19/26 Due: 02/19/27

Colesevelam for Children With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01258075 Org: User:
Start: 02/24/11 End: 04/21/20 Due: 04/21/21

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Phase: N/A Priority: Normal
NCT ID: NCT06644781 Org: User:
Start: 03/27/25 End: 11/01/29 Due: 11/01/30

Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00890591 Org: User:
Start: 08/31/06 End: 08/31/07 Due: 08/31/08

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

Phase: N/A Priority: Normal
NCT ID: NCT04622319 Org: User:
Start: 12/04/20 End: 12/31/30 Due: 12/31/31

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Phase: N/A Priority: Normal
NCT ID: NCT01124630 Org: User:
Start: 05/31/10 End: 08/31/13 Due: 08/31/14

Cancer Venous Thromboembolism (VTE)

Phase: N/A Priority: Normal
NCT ID: NCT02073682 Org: User:
Start: 07/16/15 End: 09/15/17 Due: 09/15/18

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Simvastatin for at Least 4 Weeks.

Phase: N/A Priority: Normal
NCT ID: NCT00753779 Org: User:
Start: 11/30/02 End: 04/30/05 Due: 04/30/06

Antibody DS-8273a Administered in Combination With Nivolumab in Subjects With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02991196 Org: User:
Start: 12/01/16 End: 09/22/17 Due: 09/22/18

A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05203692 Org: User:
Start: 02/02/22 End: 03/22/23 Due: 03/22/24

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Phase: N/A Priority: Normal
NCT ID: NCT01499043 Org: User:
Start: 05/25/12 End: 03/11/13 Due: 03/11/14

Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00806286 Org: User:
Start: 12/31/08 End: 08/31/12 Due: 08/31/13

Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00986440 Org: User:
Start: 07/31/09 End: 10/29/12 Due: 10/29/13

A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)

Phase: N/A Priority: Normal
NCT ID: NCT06812117 Org: User:
Start: 01/25/25 End: 04/13/26 Due: 04/13/27

A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01862939 Org: User:
Start: 04/30/11 End: 09/30/11 Due: 09/30/12